Bioactivity-guided isolation of anti-proliferative compounds from Curcuma zedoaria against triple negative breast cancer cells
- 17 March 2025
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Analytical Methods
- Vol. 17 (13) , 2740-2748
Abstract
Triple-negative breast cancer (TNBC) presents limited clinically effective treatment options. Curcuma zedoaria (C. zedoaria), a traditional medicine, has been used in China to treat various cancers including TNBC, although its active components remain unclear. Herein, we applied multidimensional liquid chromatography combined with bioactivity assay to discover anti-proliferative compounds against TNBC cells from C. zedoaria. Initially, 26 fractions were generated through first-dimensional reverse-phase liquid chromatography and profiled using SUM159 cells for its anti-proliferative activity. Two active fractions were identified and separated. Following the third-dimensional separation, we successfully isolated two compounds, diarylheptanoid a and diarylheptanoid b, and found that both compounds displayed moderate potency in inhibiting SUM159 proliferation with IC50 values of 19.82 ± 3.08 μM and 28.16 ± 1.97 μM, respectively. Transcriptome analysis revealed that the differentially expressed genes induced by diarylheptanoid a were mainly concentrated with the actin function and involved in motor protein pathways. This study suggests that diarylheptanoids may contribute to the anti-TNBC effects of C. zedoaria and provide potential scaffolds for anti-TNBC drug development.Keywords
Funding Information
- National Natural Science Foundation of China (82173962)
- Department of Education of Liaoning Province (JYTMS20230485)
This publication has 34 references indexed in Scilit:
- Next-generation biomarkers for prognostic and potential therapeutic enhancement in Triple negative breast cancerCritical Reviews in Oncology/Hematology, 2024
- Emerging roles of deubiquitinating enzymes in actin cytoskeleton and tumor metastasisCellular Oncology, 2024
- Herb pairs containing Curcumae Rhizoma (Ezhu): A review of bio-active constituents, compatibility effects and t-copula function analysisJournal of Ethnopharmacology, 2023
- The signaling pathways and targets of traditional Chinese medicine and natural medicine in triple-negative breast cancerJournal of Ethnopharmacology, 2021
- Curcumol enhances the sensitivity of doxorubicin in triple-negative breast cancer via regulating the miR-181b-2-3p-ABCC3 axisBiochemical Pharmacology, 2020
- Recent advances of modern sample preparation techniques for traditional Chinese medicinesJournal of Chromatography A, 2019
- Discovery of β2- adrenoceptor agonists in Curcuma zedoaria Rosc using label-free cell phenotypic assay combined with two-dimensional liquid chromatographyJournal of Chromatography A, 2018
- The role of curcumae rhizoma-sparganii rhizoma medicated serum in epithelial-mesenchymal transition in the triple negative breast cancerBiomedicine & Pharmacotherapy, 2018
- Three New Polyoxypregnane Glycosides from Marsdenia tenacissimaHelvetica Chimica Acta, 2005
- Activator Protein 1 Activation following Hypoosmotic Stress in HepG2 Cells Is Actin Cytoskeleton DependentJournal of Surgical Research, 2001